Navigation Links
Kill the cancer, not the patient: New toxicity testing approach could make chemo drugs safer
Date:11/18/2009

For cancer patients on chemotherapy, the "cure" can be as deadly as the disease itself. Adverse drug reactions are one of the leading causes of death among patients receiving cancer treatment.

Jackson Laboratory Professor Gary Churchill wants to change that. With a new two-year, $1 million grant from the National Cancer Institute, Churchill is launching a radical new approach to testing three chemotherapeutic drugs for potential toxic effects.

Chemo drugs are supposed to be toxicto cancer cells. But they're notorious for their unpredictable effectiveness and for causing systemic toxic reactions in patients.

"Adverse drug reactions can be difficult to study in humans," Churchill says. "Every individual is genetically unique and lives in an uncontrolled environment. That's why we need animal model systems to fully understand the genetic basis of drug response."

Testing chemo drugs in animal models is not new, but Churchill's approach is. Instead of working with one hybrid strain of mouse, as is the pharmaceutical industry standard, The Jackson Laboratory is developing a new mouse variety that is designed to maximize genetic diversity. Each one of these "Diversity Outbred Mice" will be genetically unique and, as a whole, the population approximates the genetic diversity observed in human populations.

To develop the Diversity Outbred Mice, Churchill is teaming up with Neal Goodwin, Ph.D., who directs cancer studies at JAXWest, The Jackson Laboratory's facility in Sacramento, Calif.

Sophisticated genetic mapping and live-animal imaging techniques will enable Churchill and Goodwin to home in on the gene variations found in mice that exhibit a toxic reaction. "So in terms of the information we're getting, it's almost like testing chemo drugs on every person on Earth," Churchill says. "This sets the scene for future, highly reliable screens for cancer patients."

The three drugs in the studydoxorubicin, cy
'/>"/>

Contact: Joyce Peterson
joyce.peterson@jax.org
207-288-6058
Jackson Laboratory
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Avocados may help prevent oral cancer, OSU study shows
2. St. Jude identifies the specific cell that causes eye cancer, disproving long-held theory
3. Chemical in red wine, fruits and vegetables stops cancer, heart disease, depending on the dose
4. Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds
5. T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role
6. Fruits, vegetables and teas may protect smokers from lung cancer, UCLA researchers report
7. Control switches found for immune cells that fight cancer, viral infection
8. Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds
9. Landmark study opens door to new cancer, aging treatments
10. In lung cancer, silencing one crucial gene disrupts normal functioning of genome
11. UT Southwestern researchers disrupt biochemical system involved in cancer, degenerative disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... 29, 2010) Polymer strands wriggle their way through ... to there and do their jobs. New theoretical research ... journey takes. , That,s a good thing to ... and proteins -- all of which count as polymers ... in biosensors or as drug-delivery devices. , ...
(Date:7/29/2010)... black carbon to sulfate in the atmosphere increases climate ... Iowa professor and his colleagues and published in the ... . , Black carbons -- arising from such sources ... widely considered a factor in global warming and are ... according to Greg Carmichael, Karl Kammermeyer Professor of Chemical ...
(Date:7/29/2010)... Washington, D.C (July 29, 2010) While pundits write ... climate changes are already being felt across the world. ... ways that managers have never before seen. , ... these changes. In that effort, Island Press and EcoAdapt ... Climate Adaptation Knowledge Exchange (CAKE) at www.cakex.org . ...
Breaking Biology News(10 mins):Polymer passage takes time 2Study finds black carbon implicated in global warming 2CAKE offers way forward for climate change adaptation 2Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research 4987 1Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research 4987 2Latino HIV AIDS Crisis Demands Attention Health Care Professionals from Across the United States Gather in New York City for National Conference on 57001 1Latino HIV AIDS Crisis Demands Attention Health Care Professionals from Across the United States Gather in New York City for National Conference on 57001 2Latino HIV AIDS Crisis Demands Attention Health Care Professionals from Across the United States Gather in New York City for National Conference on 57001 3LeBow 26amp 3B Associates Moves to New Office in Manhattan 56998 1LeBow 26amp 3B Associates Moves to New Office in Manhattan 56998 2
... A team including researchers at the HudsonAlpha Institute ... number of other organizations, today publishes a comprehensive ... glioblastoma. These results are the first from the ... effort funded by the National Cancer Institute and ...
... 4, 2008) A variety of organismsfrom bacteria ... the timing and duration of fundamental biological processes is ... even under fluctuating environmental conditions. In recent years, ... basis of these rhythms and how they translate into ...
... that obesity and Type 2 Diabetes Mellitus (T2DM) can contribute ... the first study to show that obesity can cause ... Disease Volume 15:1 (September 2008) . , In ... Monte, MD, MPH, of Rhode Island Hospital, utilized chronic high ...
Other Biology News:Collaboration between researchers yields more comprehensive portrait of brain cancer 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2
(Date:7/27/2010)... mechanisms critical to interactions between hot plasma and ... reactor, part of work aimed at developing coatings ... reactors. , Fusion powers the stars and could ... A fusion power plant would produce 10 times ... and because the deuterium fuel is contained in ...
(Date:7/27/2010)... point to accelerated growth in China ,s domestic market:  rising ... services, central government policy continues to urge greater consumption of goods. ... Wednesday, September 8 , executives and managers can learn how to ... , , , ... companies now figuring out how to approach the high growth market, ...
(Date:7/27/2010)... , July 27 Adeona Pharmaceuticals, Inc., ... Caudill , B.B.A., has been appointed Vice President of Finance ... 15 years of biotechnology-related accounting and Securities and Exchange Commission ... , ... in a variety of financial reporting positions at Aastrom Biosciences, ...
(Date:7/26/2010)... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) will conduct ... on Thursday, August 5, 2010 at 4:30 p.m. ... , , ... call by telephone, please dial (877) 280-7291 ( United States ) ... live and can be accessed on the "Events" page of the ...
Breaking Biology Technology:Findings show promise for nuclear fusion test reactors 2Findings show promise for nuclear fusion test reactors 3Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 2Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 3Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller 2Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller 3
... Quarter Target Agreed, GENEVA, Switzerland, February 11 ... have agreed with Molecular Vision and The Imperial ... of Molecular Vision. Following the,initial acquisition of 10.9% ... month, it has now been agreed by all ...
... on Status of Integration Planning -, SOUTH ... Sheets: VXGN), a biopharmaceutical company, and Raven,biotechnologies, inc. ... monoclonal antibody therapeutics (MAbs) for treating cancer, announced,today ... to the,proposed merger with Raven biotechnologies has been ...
... Calif., Feb. 11 Cepheid (Nasdaq:,CPHD) today announced ... as,Senior Vice President, Chief Financial Officer on April ... operations and investor,relations. Mr. Miller will report to ... Sluis, who retired from Cepheid effective,December 31, 2007., ...
Other Biology Technology:Acrongenomics on Track to Acquire Molecular Vision 2Acrongenomics on Track to Acquire Molecular Vision 3Acrongenomics on Track to Acquire Molecular Vision 4VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 2VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 3VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 4VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 5Cepheid Appoints Senior VP, Chief Financial Officer to Management Team 2
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
Biology Products: